PolyOne Selects New Commercial Manager
Advertisement
PolyOne Corporation announced that Mark Stewart has joined the Company as commercial manager for the European Inks and Formulators groups based in the United Kingdom (UK).
Stewart is responsible for identifying new opportunities to grow each group globally. The PolyOne Formulators group manufactures customized plastisols, colorants and additives for numerous market sectors. The PolyOne Inks group markets screen printing inks for textile end-uses under the Wilflex® and Plast-O-Meric® brands. Stewart, will report to Peter M. Juhl, business manager and director of the UK Formulators group.
Stewart, 44, brings 16 years of polymer experience with him, having held a number of senior management positions within the specialist polymer industry. He also brings a wealth of knowledge and experience in global account management.
Mark Stewart is an excellent addition to our team at PolyOne," Juhl said. "His knowledge of the polymer industry and customer needs will be critical in our ability to grow the Inks and Formulators groups in Europe."
Based in PolyOne's UK Widnes facility, Stewart is delighted to join the PolyOne team at such an exciting time and sees his role as an integral part of achieving each group's future growth expectations.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Abcr GmbH and Enzymicals AG deepen the cooperation
Dowpharma Consolidates Biopharmaceutical Process Development to San Diego

How acids behave in ultracold interstellar space

Made to order: Researchers discover a new form of crystalline matter

Tracking down polluters

New path suggested for nuclear fusion
Roche submits oral flu drug Tamiflu for regulatory approval in Europe
Abgenix Announces Initiation of Phase II Clinical Trial of ABX-EGF in Non-Small Cell Lung Cancer

Electroplating delivers high-energy, high-power batteries

Helmholtz-Zentrum Dresden-Rossendorf (HZDR) e.V. - Dresden, Germany
